Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C. (Q43843771)
Jump to navigation
Jump to search
scientific article published in January 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C. |
scientific article published in January 2002 |
Statements
1 reference
Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C. (English)
1 reference
Ronald A Fleming
1 reference
Jeffrey Drees
1 reference
Brian W Loggie
1 reference
Gregory B Russell
1 reference
Kim R Geisinger
1 reference
Reba T Morris
1 reference
Debbie Sachs
1 reference
Richard P McQuellon
1 reference
1 January 2002
1 reference
1 reference
12
1 reference
1
1 reference
31-37
1 reference
Identifiers
1 reference
1 reference